Interspecies variability in protein binding of antibiotics basis for translational PK/PD studies-a case study using cefazolin.

antibiotics cefazolin equilibrium dialysis fraction unbound interspecies differences pharmacokinetics plasma protein binding ultrafiltration

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
20 Feb 2024
Historique:
medline: 20 2 2024
pubmed: 20 2 2024
entrez: 20 2 2024
Statut: aheadofprint

Résumé

For antimicrobial agents in particular, plasma protein binding (PPB) plays a pivotal role in deciphering key properties of drug candidates. Animal models are generally used in the preclinical development of new drugs to predict their effects in humans using translational pharmacokinetics/pharmacodynamics (PK/PD). Thus, we compared the protein binding (PB) of cefazolin as well as bacterial growth under various conditions

Identifiants

pubmed: 38376186
doi: 10.1128/aac.01647-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0164723

Auteurs

Hifza Ahmed (H)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Michaela Böhmdorfer (M)

Department of Clinical Pharmacy, University of Vienna, Vienna, Austria.

Sabine Eberl (S)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Walter Jäger (W)

Department of Clinical Pharmacy, University of Vienna, Vienna, Austria.

Markus Zeitlinger (M)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Classifications MeSH